Proteins Involved in Orthopoxvirus Intracellular Egress
参与正痘病毒细胞内流出的蛋白质
基本信息
- 批准号:7989661
- 负责人:
- 金额:$ 21.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAntiviral AgentsAttenuated VaccinesBiologicalBiological AssayBiologyCell membraneCellsCytoplasmDNA VirusesDiseaseDisease OutbreaksDominant-Negative MutationEpidemicExpression LibraryFamilyFamily memberGPA33 geneGoalsGolgi ApparatusHela CellsHumanHybridsInfectionIntracellular TransportKinesinLeadLightMediatingMembraneMicroscopicMicrotubulesMolecularMolecular MotorsMonkeypoxMorphogenesisMotorMutationMyosin Type VOrthopoxvirusPlayPoxviridaePoxviridae InfectionsProductionProteinsRecombinant VaccinesReportingRoleSiteSmallpoxSmallpox VaccineSmallpox VirusesSystemSystemic infectionTestingThickVaccinia virusViralViral ProteinsVirionVirusWorkYeastsbaseepizooticexpression vectorin vivoinsightmembermonolayermutantnovelpreventprotein functionprotein protein interactionpublic health relevancetraffickingvectorvirus envelope
项目摘要
DESCRIPTION (provided by applicant): Poxviruses include a large family of DNA viruses capable of infecting and causing disease in humans. While the most notorious member variola, the causative agent of smallpox, was eradicated from natural infection, there are still concerns about a clandestine release during a biological attack. In addition, monkeypox and other members of the family have raised concern about epizootic infections capable of causing epidemic. Poxviruses produce two infectious forms, enveloped and unenveloped virions. While unenveloped virions make up the majority of their progeny, it is the enveloped form that is required for efficient cell-to-cell spread and infection. Envelopment occurs in the cytoplasm of infected cells and only 7 proteins encoded by the virus are known to be unique to the enveloped form. The long-term goal of this project is to understand how these 7 proteins coordinate the monumental task of creating and releasing an enveloped virion. The immediate goal is to understand the function of the protein encoded by F12L. Our Hypothesis is that F12 interacts with the actin motor myosin V to facilitate virion transport through the actin cortex for egress. Our specific aims are: 1) Test for functional domains of F12, 2) Characterization of the kinesin-A36-F12 interaction, 3) Screen for additional proteins that interact with F12 and MyoV. The results obtained will provide greater insight into the interaction poxviruses have with their host at a molecular level and give us a better understanding of poxvirus morphogenesis and egress.
PUBLIC HEALTH RELEVANCE: Even though natural occurring smallpox was eradicated, concern for orthopoxviruses, ranging from a clandestine release of smallpox to outbreaks of epizootic infections such as monkeypox, still exist. Understanding the biology of poxviruses is still a priority not only for preventing epidemics but also for understanding basic mechanisms of biology. The results from this study will provide new insights into poxvirus infections, which will provide new targets for antivirals and treatments against their infections.
描述(由申请方提供):痘病毒包括能够感染人类并引起人类疾病的DNA病毒大家族。虽然最臭名昭著的成员天花,天花的病原体,从自然感染中被根除,但仍然有人担心在生物攻击期间秘密释放。此外,猴痘和该家族的其他成员引起了人们对能够引起流行病的动物流行病感染的关注。痘病毒产生两种感染形式,包膜和无包膜病毒粒子。虽然无包膜病毒粒子构成其后代的大部分,但有效的细胞间传播和感染需要包膜形式。包膜发生在受感染细胞的细胞质中,已知只有7种病毒编码的蛋白质是包膜形式所特有的。该项目的长期目标是了解这7种蛋白质如何协调创建和释放包膜病毒体的艰巨任务。目前的目标是了解F12 L编码蛋白的功能。我们的假设是,F12与肌动蛋白运动肌球蛋白V相互作用,以促进病毒粒子运输通过肌动蛋白皮质的出口。我们的具体目标是:1)测试F12的功能结构域,2)表征驱动蛋白-A36-F12相互作用,3)筛选与F12和MyoV相互作用的其他蛋白。所获得的结果将提供更深入的了解痘病毒与其宿主在分子水平上的相互作用,并使我们更好地了解痘病毒的形态发生和出口。
公共卫生相关性:尽管自然发生的天花已被根除,但对正痘病毒的担忧,从天花的秘密释放到动物流行病感染如猴痘的爆发,仍然存在。了解痘病毒的生物学仍然是一个优先事项,不仅是为了预防流行病,而且是为了了解生物学的基本机制。这项研究的结果将为痘病毒感染提供新的见解,这将为抗病毒药物和抗感染治疗提供新的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN M WARD其他文献
BRIAN M WARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN M WARD', 18)}}的其他基金
Understanding the Function of F13 as a Matrix Protein for Poxvirus Intracellular Envelopment
了解 F13 作为痘病毒细胞内包膜基质蛋白的功能
- 批准号:
10594179 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Uncovering poxvirus proteins involved in regulating the IMV to EV transition
揭示参与调节 IMV 到 EV 转变的痘病毒蛋白
- 批准号:
8282257 - 财政年份:2012
- 资助金额:
$ 21.65万 - 项目类别:
Uncovering poxvirus proteins involved in regulating the IMV to EV transition
揭示参与调节 IMV 到 EV 转变的痘病毒蛋白
- 批准号:
8543623 - 财政年份:2012
- 资助金额:
$ 21.65万 - 项目类别:
Proteins Involved in Orthopoxvirus Intracellular Egress
参与正痘病毒细胞内流出的蛋白质
- 批准号:
8066722 - 财政年份:2010
- 资助金额:
$ 21.65万 - 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
- 批准号:
7350933 - 财政年份:2007
- 资助金额:
$ 21.65万 - 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
- 批准号:
7567605 - 财政年份:2007
- 资助金额:
$ 21.65万 - 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
- 批准号:
7755840 - 财政年份:2007
- 资助金额:
$ 21.65万 - 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
- 批准号:
8840138 - 财政年份:2007
- 资助金额:
$ 21.65万 - 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
- 批准号:
8695900 - 财政年份:2007
- 资助金额:
$ 21.65万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 21.65万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 21.65万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 21.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 21.65万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 21.65万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 21.65万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 21.65万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 21.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 21.65万 - 项目类别:














{{item.name}}会员




